These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19193545)

  • 41. [Pharmacology. The proper use of drugs. 10/12. The preparation and administration of antineoplastic agents and adjuvants].
    Valnet-Rabier MB; Limat S; Woronoff-Lemsi MC; Belon JP
    Soins; 2000 Mar; (643):51-2. PubMed ID: 11075232
    [No Abstract]   [Full Text] [Related]  

  • 42. Carcinoid tumors: what should increase our suspicion?
    Aggarwal G; Obideen K; Wehbi M
    Cleve Clin J Med; 2008 Dec; 75(12):849-55. PubMed ID: 19088003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Start of the new German Register for Neuroendocrine Tumors].
    Krankenpfl J; 2004; 42(5-6):159. PubMed ID: 15527224
    [No Abstract]   [Full Text] [Related]  

  • 44. Carcinoid tumor presenting as a primary mesenteric mass: a case report and review of the literature.
    Yamanuha J; Ballinger R; Coon D; Navin J
    Hawaii Med J; 2009 Jul; 68(6):137-9. PubMed ID: 19653425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What was your experience administering a biologic agent for the first time?
    Gillespie TW
    ONS Connect; 2007 Jul; 22(7):13. PubMed ID: 17876940
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
    Unek IT; Celtik A; Yener S; Yavuzsen T; Alacacioglu A; Cokmert S; Oztop I; Demirkan B; Dicle O; Sagol O; Bekis R; Yilmaz U
    J BUON; 2009; 14(1):135-8. PubMed ID: 19365885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    Arch Surg; 2009 Jun; 144(6):527-31. PubMed ID: 19528385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary carcinoid hepatic tumour: a case report].
    Jarboui S; Jerraya H; Moussi A; Daldoul S; Morched Abdesselem M; Zaouche A
    Tunis Med; 2008 Apr; 86(4):386-8. PubMed ID: 19476145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral mucositis in radiation/chemotherapy: treatment similarities.
    Haas ML
    Oncology (Williston Park); 2009 Jul; 23(8 Suppl):23-6. PubMed ID: 19860039
    [No Abstract]   [Full Text] [Related]  

  • 50. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors.
    Burnik FS; Yalçin S
    Chemotherapy; 2009; 55(5):381-5. PubMed ID: 19752553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Carcinoid tumor of the larynx].
    Mani R; Belcadhi M; Chahed H; Ben Abdelkader A; Bouzouita K
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):71-4. PubMed ID: 19268278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
    Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
    [No Abstract]   [Full Text] [Related]  

  • 53. Aseptic non-touch technique.
    Stronach K
    Aust Nurs J; 2009 Jun; 16(11):51. PubMed ID: 19588721
    [No Abstract]   [Full Text] [Related]  

  • 54. [Rectal carcinoids on the rise - update].
    Scherübl H; Klöppel G
    Z Gastroenterol; 2009 Apr; 47(4):365-71. PubMed ID: 19358064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Readers share comments and questions about extravasation management.
    Schulmeister L
    Oncol Nurs Forum; 2007 Mar; 34(2):275; author reply 276-80. PubMed ID: 17573287
    [No Abstract]   [Full Text] [Related]  

  • 56. L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
    Kim HS; Yi SY; Jun HJ; Ahn JS; Ahn MJ; Lee J; Kim Y; Cui ZY; Hong HJ; Kim JM; Li S; Hwang IG; Park K
    APMIS; 2009 Feb; 117(2):140-6. PubMed ID: 19239436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
    Nissen NN; Kim AS; Yu R; Wolin EM; Friedman ML; Lo SK; Wachsman AM; Colquhoun SD
    Am Surg; 2009 Oct; 75(10):1025-9. PubMed ID: 19886158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary carcinoid tumor of the gallbladder.
    Baikoussis NG; Karvelas FP; Apostolopoulos NV
    Minerva Chir; 2009 Feb; 64(1):119-20. PubMed ID: 19202542
    [No Abstract]   [Full Text] [Related]  

  • 59. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
    Oberg K
    Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neuroendocrine tumors: an overview].
    Helmberger T
    Radiologe; 2009 Mar; 49(3):197. PubMed ID: 19255737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.